Snoozebox, which provides portable hotels at venues such as grand prix racing track Silverstone and music festival Glastonbury, saw Lorcán Ó Murchú resign on Monday.
Not to be caught napping, the firm announced non-executive chairman Chris Errington, who has risen rapidly within the group after joining it in January, will take the role of part-time executive chairman.
Additionally, in a trading update, the company warned the sleepless nights may not be over soon, offering up “cautious view” for the rest of the year after issuing a profit warning.
Shares, which hit the dreamy heights of 72p back in 2013, fell out of bed this week, losing 72.8% to 0.43p, despite a big rise on Friday.
It was a contributing factor to the AIM All-Share’s slip this week, though the index, much like Snoozebox, recovered slightly on Friday to sit (or lie) 2 points lower at 729.
The company started the week by revealing in its full-year results statement it would require further funding for short-term working capital purposes.
The big loser of the week, however, was Andalas Energy and Power PLC (LON:ADL), after it agreed a deal to acquire a 30% stake in Tuba Obi East Technical Assistance Contract (TOE).
The farm-in was funded by a placing of 1.3bn shares at 0.2p per share, with the £2.6mln raised to be used to fund its work programme. The deal is classified as a reverse takeover.
The revamped web site must be a corker because the shares rose more than 70% to 0.36p this week, with the only news out that its site had been updated.
More likely is the share price continues to be boosted by the announcement last week that it lodged its application to start drilling at the Hanns Camp prospect in Australia.
Away from the thrill a minute world of Big Data, there was mixed fortunes in the mining space.
The company also said it only has sufficient working capital to last until early May.
But it was a better week for Goldstone Resources Ltd (LON:GRL), which must have felt like the belle of the Ball this week.
Goldstone shares climbed almost 80% to 3.18p.
Away from the miners, another company on the rise was Summit Therapeutics PLC(LON:SUMM), which received a shot in the arm from the US patent and trademark office, after it granted a "composition of matter" patent to its C-Difficile treatment ridinilazole. Shares rose by 25% to 132p.